FierceBiotech Feb 9, 2026 The Data Multiplier Effect: When Expertise, Monitoring, Systems, and AI Align
FierceBiotech Feb 6, 2026 UniQure pauses Fabry gene therapy dosing in 2 groups after toxicities emerge
FierceBiotech Feb 6, 2026 Pfizer-backed Priovant scores again with fast-rising brepocitinib in midstage study
FierceBiotech Feb 6, 2026 Qiagen 'open for discussion' on shareholder value, but CEO stays mum on takeover talk
FierceBiotech Feb 5, 2026 Racing BMS and J&J, Bayer links asundexian to 26% stroke reduction to unblock path to FDA
FierceBiotech Feb 5, 2026 GE HealthCare posts higher full-year revenues amid turbulent tariff backdrop
FierceBiotech Feb 5, 2026 Quell halts liver transplant Treg trial to focus on preclinical 'chill not kill' candidate
FierceBiotech Feb 5, 2026 FDA’s rare pediatric disease voucher program revived by 2026 government funding bill